Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01473342 · ClinicalTrials.gov registry record · NA
Mila Blooms Intervention Study
A NA study of Childhood Cancer, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 21
- Enrollment target
- 1
- Study location
NCT01473342: Completed NA study of Childhood Cancer, sponsored by Duke University.
NCT01473342 is a NA study of Childhood Cancer that has completed, run by Duke University. The registered enrollment target is 21 participants, below the 1,471-participant average among 23 other Childhood Cancer trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01473342, a NA study of Childhood Cancer, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is focused on the development and pilot/feasibility testing of a smartphone application to promote a healthy diet, increase physical activity, and prevent weight gain in adolescent survivors of childhood cancer.
Primary Outcome
Test the feasibility of the Mila Blooms intervention at changing diet, physical activity, body mass index (BMI), and social cognitive mediators of health behavior change.
Conditions Studied
Interventions
- BEHAVIORAL Mila Blooms
Study Locations (1)
North Carolina
- Duke University Medical Center, Dept. of Community and Family Medicine - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2011-04 |
| Est. Completion | 2014-07 |
| Phase | NA |
What the finished NCT01473342 record still lists
NCT01473342 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 21 participants, a relatively small participant target, below the 1,471-participant average among 23 other Childhood Cancer trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Childhood Cancer appearing as the primary indexed condition, and to 1 intervention - of which Mila Blooms is the first listed.
NCT01473342 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT01473342 about?
NCT01473342 is a clinical study titled "Mila Blooms Intervention Study". This study is focused on the development and pilot/feasibility testing of a smartphone application to promote a healthy diet, increase physical activity, and prevent weight gain in adolescent survivors of childhood cancer.
What is the current status of trial NCT01473342?
This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2011-04. Estimated completion is 2014-07.
What conditions does trial NCT01473342 study?
This clinical trial studies the following conditions: Childhood Cancer.
What interventions are being tested in trial NCT01473342?
The interventions under investigation include: Mila Blooms (BEHAVIORAL).
Who is sponsoring clinical trial NCT01473342?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01473342 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Childhood Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01473342's enrollment target sits among peer trials
21 19th of 23 higher than 5 of 23 other Childhood Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Childhood Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Preparing for Life and Academics for Young Childhood Cancer Survivors
RECRUITING · NA
-
Assessment of Remote Approaches for Identification of Autonomic Dysfunction Among Survivors of Leukemia and Lymphoma
RECRUITING · NA
-
Patients At Risk for Sensory Screening (HPARSS) to Enhance Sensory Deficit Screening in Childhood Cancer Survivors
RECRUITING · NA
-
Light Therapy for Chemotherapy Induced Peripheral Neuropathy in Childhood Cancer Survivors
RECRUITING · NA
-
Mobile App to Help Survivors of Childhood Cancer Navigate Long-Term Follow-Up Care
RECRUITING · NA
-
Proof-of-Concept Testing of the Cardiovascular Health Equity Through Food (CHEF) Intervention in Childhood Cancer Survivors
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02447874 · 21 participants · Phase 1
Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease
- NCT03826992 · 21 participants · Phase 1
Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia
- NCT04107077 · 21 participants · Phase 2
Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer
- NCT04158635 · 21 participants · Phase 1
Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia